Researchers Submit Patent Application, "Heterocyclic Compounds, Preparation Methods And Uses Thereof", for Approval (USPTO 20240156820).

A patent application has been submitted for the invention of heterocyclic compounds that can be used to inhibit RAS and treat diseases such as pancreatic, colorectal, and lung cancers. RAS proteins play a crucial role in cell proliferation and survival, and mutations in RAS genes are common in various cancers. The patent application describes specific compounds and their crystalline forms, as well as methods of preparing and using these compounds for therapeutic purposes. The compounds can be used as monotherapy or in combination with other anti-cancer therapies. [Extracted from the article]

Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)